Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 2016

View Archived Issues

Emulate enters translational R&D collaboration

Roche reviews highlights of third quarter 2016

TxCell and UBC begin strategic collaboration to develop CAR-Tregs in solid organ transplantation

BlackThorn Therapeutics closes series A financing

Merck & Co. patents BTK inhibitors

Rigel Pharmaceuticals discloses TGF-beta and/or GDF-8 inhibitors

MedImmune begins phase I study of anti-ILT-7 antibody

AbbVie describes TRPV3 receptor antagonists

FDA approves Zinplava to reduce recurrence of C. difficile infection

FDA approves updated labeling for Xtandi

Gilead Sciences reports results of three phase II studies of selonsertib

Merck & Co.'s KEYNOTE-045 study meets primary endpoint

Daiichi Sankyo updates decision on phase III study of pexidartinib in tenosynovial giant cell tumor

Bristol-Myers Squibb develops IDO inhibitors

Phase II results on OMS-721 in stem cell transplant-associated thrombotic microangiopathy

Daiichi Sankyo reports Japanese phase III results for prasugrel in ischemic cerebrovascular disease

Gilead Sciences provides results from phase III studies of sofosbuvir/velpatasvir/voxilaprevir

Phase III efficacy trials of revefenacin in COPD meet primary endpoint

NeuroVive and Arbutus terminate NVP-018 agreement

FDA committee votes in favor of approving SER-120 for nocturia

FDA accepts resubmitted NDA for safinamide

Phase III study of denosumab in MM meets primary enpoint

VBI-1901 shows promising preclinical results

GSK submits BLA for Shingrix

Janssen presents phase I results for ExPEC4v

Multiplatform imaging of systemic amyloidosis with the new peptide p5+14

New mutations in known disease-associated genes

Discovery of new biomarkers for conditions

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...